Invests across pharmaceuticals, biotechnology, diagnostics, life science tools, medical technology, healthcare distribution and services, and selected consumer health businesses. The segment comprises three complementary portfolios, combining established healthcare franchises, specialized European businesses, and biotechnology innovation, with a shared focus on long-term value creation.
Updated 2026-10-25